慢性肾脏病与瓣膜性心脏病:KDIGO争议会议结论
慢性肾脏病(CKD)是瓣膜性心脏病(VHD)的重要危险因素,二尖瓣环和主动脉瓣钙化在CKD患者中高发,常导致瓣膜狭窄和反流等并发症。VHD(尤其二尖瓣反流和主动脉瓣狭窄)与CKD患者生存率显著降低相关。本KDIGO综述旨在总结CKD合并VHD的流行病学、病理生理、诊断和治疗的知识缺口、争议领域和研究优先方向。
要点
- CKD患者二尖瓣环和主动脉瓣钙化高发,常导致瓣膜狭窄和反流。
- VHD(尤其二尖瓣反流和主动脉瓣狭窄)与CKD患者生存率显著降低相关。
- 一般人群的VHD知识不一定适用于CKD患者,因病理生理可能不同且合并症多。
核心结论
- CKD是VHD的重要危险因素,VHD与CKD患者生存率显著降低相关。
- 一般人群的VHD知识不一定适用于CKD患者,需专门研究。
研究设计与样本
- KDIGO争议会议综述,总结CKD与VHD的流行病学、病理生理、诊断和治疗。
主要发现
- 二尖瓣环和主动脉瓣钙化在CKD患者中高发,常导致瓣膜狭窄和反流。
- VHD并发症包括传导系统异常和心内膜炎。
- CKD患者合并症高发且围手术期并发症和死亡风险升高。
局限性
- 综述旨在总结知识缺口和争议,未提供具体临床推荐或数值标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) is a major risk factor for valvular heart disease (VHD). Mitral annular and aortic valve calcifications are highly prevalent in CKD patients and commonly lead to valvular stenosis and regurgitation, as well as complications including conduction system abnormalities and endocarditis. VHD, especially mitral regurgitation and aortic stenosis, is associated with significantly reduced survival among CKD patients. Knowledge related to VHD in the general population is not always applicable to CKD patients because the pathophysiology may be different, and CKD patients have a high prevalence of comorbid conditions and elevated risk for periprocedural complications and mortality. This Kidney Disease: Improving Global Outcomes (KDIGO) review of CKD and VHD seeks to improve understanding of the epidemiology, pathophysiology, diagnosis, and treatment of VHD in CKD by summarizing knowledge gaps, areas of controversy, and priorities for research.
引用
- Marwick TH, Amann K, Bangalore S, et al. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019. PMID: 31543156. doi:10.1016/j.kint.2019.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。